A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Pharmacokinetic Profile of JNJ-56021927 When Administered as the Tablet Formulation in Healthy Male Japanese Subjects
Latest Information Update: 27 Aug 2019
At a glance
- Drugs Apalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors Janssen Pharmaceutical KK
- 20 Aug 2019 Pooled analysis population pharmacokinetic results of Apalutamide from seven clinical trials were published in the Clinical Pharmacokinetics.
- 10 Jan 2017 Status changed from active, no longer recruiting to completed.
- 18 Nov 2016 Status changed from recruiting to active, no longer recruiting.